Carbamazepine malabsorption: a case report. 1988

J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
Department of Pharmacy, Miami Children's Hospital, FL 33155.

UI MeSH Term Description Entries
D008297 Male Males
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
January 2007, Przeglad lekarski,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
February 1986, Italian journal of neurological sciences,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
January 1993, Epilepsia,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
January 1999, Acta gastroenterologica Latinoamericana,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
June 1969, Ugeskrift for laeger,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
March 1995, Psychiatry and clinical neurosciences,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
January 2017, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
March 1988, Irish journal of medical science,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
January 2019, Indian journal of pharmacology,
J T Gilman, and M S Duchowny, and T J Resnick, and E R Hershorin
January 2002, Revista de neurologia,
Copied contents to your clipboard!